ELTX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Elicio Therapeutics Inc (ELTX).


$55.04M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

ELTX Market Cap. (MRY)


ELTX Shares Outstanding (MRY)


ELTX Assets (MRY)


Total Assets

$28.18M

Total Liabilities

$39.49M

Total Investments

$0

ELTX Income (MRY)


Revenue

$0

Net Income

-$51.90M

Operating Expense

$44.99M

ELTX Cash Flow (MRY)


CF Operations

-$37.07M

CF Investing

-$84.00K

CF Financing

$42.32M

ELTX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

ELTX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$28,178,000 (3.80%)

$27,146,000 (19.78%)

$22,664,000 (-76.52%)

$96,513,000 (103.84%)

Assets Current

$20,693,000 (26.58%)

$16,348,000 (52.54%)

$10,717,000 (-88.25%)

$91,247,000 (115.73%)

Assets Non-Current

$7,485,000 (-30.68%)

$10,798,000 (-9.62%)

$11,947,000 (126.87%)

$5,266,000 (4.28%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$11,312,000 (-199.46%)

$11,373,000 (111.13%)

-$102,145,000 (-225.32%)

$81,507,000 (190.11%)

Property Plant & Equipment Net

$6,189,000 (-14.99%)

$7,280,000 (-14.32%)

$8,497,000 (91.50%)

$4,437,000 (4.94%)

Cash & Equivalents

$18,796,000 (38.04%)

$13,616,000 (74.63%)

$7,797,000 (-91.22%)

$88,756,000 (156.47%)

Accumulated Other Comprehensive Income

-$175,000 (11.17%)

-$197,000 (0%)

$0 (0%)

-$103,000 (69.07%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$2,301,000 (-92.28%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$723,000 (-12.04%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$723,000 (-12.04%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$806,000 (0%)

Trade & Non-Trade Payables

$1,038,000 (-76.24%)

$4,369,000 (55.76%)

$2,805,000 (-40.45%)

$4,710,000 (-15.56%)

Accumulated Retained Earnings (Deficit)

-$194,101,000 (-36.50%)

-$142,203,000 (-32.89%)

-$107,008,000 (50.26%)

-$215,135,000 (-33.99%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$26,040,000 (276.46%)

$6,917,000 (-7.54%)

$7,481,000 (60.47%)

$4,662,000 (-91.75%)

Debt Current

$901,000 (-0.99%)

$910,000 (31.50%)

$692,000 (-27.31%)

$952,000 (-98.17%)

Debt Non-Current

$25,139,000 (318.50%)

$6,007,000 (-11.52%)

$6,789,000 (82.99%)

$3,710,000 (-17.22%)

Total Liabilities

$39,490,000 (150.36%)

$15,773,000 (14.72%)

$13,749,000 (-8.38%)

$15,006,000 (-89.11%)

Liabilities Current

$11,523,000 (17.99%)

$9,766,000 (42.20%)

$6,868,000 (-39.20%)

$11,296,000 (-89.49%)

Liabilities Non-Current

$27,967,000 (365.57%)

$6,007,000 (-12.70%)

$6,881,000 (85.47%)

$3,710,000 (-87.77%)

ELTX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$2,301,000 (-91.87%)

$28,312,000 (883.06%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$433,000 (-63.61%)

Selling General & Administrative Expense

$11,330,000 (-4.76%)

$11,896,000 (-18.73%)

$14,637,000 (-20.83%)

$18,488,000 (2.79%)

Research & Development Expense

$33,656,000 (41.12%)

$23,849,000 (31.76%)

$18,100,000 (-62.83%)

$48,698,000 (24.94%)

Operating Expenses

$44,986,000 (25.85%)

$35,745,000 (-14.73%)

$41,922,000 (-37.60%)

$67,186,000 (17.95%)

Interest Expense

$455,000 (-57.03%)

$1,059,000 (231.55%)

-$805,000 (-143.58%)

$1,847,000 (-79.12%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$51,898,000 (-47.46%)

-$35,195,000 (9.31%)

-$38,807,000 (28.89%)

-$54,573,000 (31.87%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$51,898,000 (-47.46%)

-$35,195,000 (9.31%)

-$38,807,000 (28.89%)

-$54,573,000 (31.87%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$51,898,000 (-47.46%)

-$35,195,000 (9.31%)

-$38,807,000 (28.89%)

-$54,573,000 (31.87%)

Weighted Average Shares

$12,202,996 (141.35%)

$5,056,225 (68.31%)

$3,004,070 (6.36%)

$2,824,482 (91.33%)

Weighted Average Shares Diluted

$12,202,996 (141.35%)

$5,056,225 (68.31%)

$3,004,070 (6.36%)

$2,824,482 (91.33%)

Earning Before Interest & Taxes (EBIT)

-$51,443,000 (-50.70%)

-$34,136,000 (13.82%)

-$39,612,000 (24.87%)

-$52,726,000 (26.01%)

Gross Profit

$0 (0%)

$0 (0%)

$2,301,000 (-91.75%)

$27,879,000 (1549.64%)

Operating Income

-$44,986,000 (-25.85%)

-$35,745,000 (9.78%)

-$39,621,000 (-0.80%)

-$39,307,000 (28.89%)

ELTX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$84,000 (-162.50%)

-$32,000 (0%)

$0 (0%)

-$382,000 (-831.71%)

Net Cash Flow from Financing

$42,321,000 (9.60%)

$38,613,000 (64455.00%)

-$60,000 (-100.06%)

$107,171,000 (104.49%)

Net Cash Flow from Operations

-$37,068,000 (-13.38%)

-$32,694,000 (14.84%)

-$38,390,000 (27.07%)

-$52,643,000 (-130.00%)

Net Cash Flow / Change in Cash & Cash Equivalents

$5,191,000 (-11.82%)

$5,887,000 (115.38%)

-$38,269,000 (-170.67%)

$54,149,000 (86.49%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$84,000 (-162.50%)

-$32,000 (0%)

$0 (0%)

-$382,000 (-831.71%)

Issuance (Repayment) of Debt Securities

$19,727,000 (97.27%)

$10,000,000 (17341.38%)

-$58,000 (-119.80%)

$293,000 (-99.09%)

Issuance (Purchase) of Equity Shares

$23,143,000 (231.75%)

$6,976,000 (348900.00%)

-$2,000 (-100.00%)

$108,475,000 (22936.84%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$22,000 (0%)

$0 (0%)

$181,000 (5933.33%)

$3,000 (100.68%)

Share Based Compensation

$1,452,000 (23.16%)

$1,179,000 (33.22%)

$885,000 (-92.65%)

$12,041,000 (155.32%)

Depreciation Amortization & Accretion

$1,178,000 (0.68%)

$1,170,000 (18.06%)

$991,000 (23.72%)

$801,000 (27.55%)

ELTX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

100.00% (1.52%)

98.50% (67.80%)

Profit Margin

-

-

-1686.50% (-774.74%)

-192.80% (93.07%)

EBITDA Margin

-

-

-1678.40% (-815.16%)

-183.40% (92.52%)

Return on Average Equity (ROAE)

766.60% (578.53%)

-160.20% (22.57%)

-206.90% (-198.99%)

-69.20% (-147.11%)

Return on Average Assets (ROAA)

-194.40% (-89.84%)

-102.40% (-55.62%)

-65.80% (-42.12%)

-46.30% (82.88%)

Return on Sales (ROS)

-

-

-1721.50% (-824.54%)

-186.20% (92.47%)

Return on Invested Capital (ROIC)

-272.80% (5.34%)

-288.20% (57.09%)

-671.60% (-148.20%)

1393.40% (366.02%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-1.2 (-0.17%)

-1.2 (-90.46%)

-0.63 (58.15%)

-1.5

Price to Sales Ratio (P/S)

-

-

10.6 (266.26%)

2.89

Price to Book Ratio (P/B)

-4.87 (-178.91%)

6.17 (2679.50%)

-0.24 (-122.42%)

1.07

Debt to Equity Ratio (D/E)

-3.49 (-351.69%)

1.39 (1127.41%)

-0.14 (-173.37%)

0.18 (112.08%)

Earnings Per Share (EPS)

-4.25 (38.94%)

-6.96 (46.05%)

-12.9 (33.16%)

-19.3 (64.46%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0.77 (-92.36%)

10.02 (413.79%)

Free Cash Flow Per Share (FCFPS)

-3.04 (52.97%)

-6.47 (49.35%)

-12.78 (31.93%)

-18.77 (-20.87%)

Book Value Per Share (BVPS)

-0.93 (-141.22%)

2.25 (106.61%)

-34 (-217.83%)

28.86 (147.10%)

Tangible Assets Book Value Per Share (TABVPS)

2.31 (-56.99%)

5.37 (-28.83%)

7.54 (-77.92%)

34.17 (6.54%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (50.00%)

-2 (-300.00%)

1 (0%)

0

Enterprise Value Over EBITDA (EV/EBITDA)

-1.07 (42.00%)

-1.84 (-365.95%)

0.69 (219.35%)

0.22

Asset Turnover

0 (0%)

0 (0%)

0.04 (-83.75%)

0.24 (147.42%)

Current Ratio

1.8 (7.29%)

1.67 (7.31%)

1.56 (-80.69%)

8.08 (1950.25%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$37,152,000 (-13.52%)

-$32,726,000 (14.75%)

-$38,390,000 (27.60%)

-$53,025,000 (-131.26%)

Enterprise Value (EV)

$53,751,763 (-11.53%)

$60,756,264 (327.15%)

-$26,746,719 (-136.99%)

-$11,286,199

Earnings Before Tax (EBT)

-$51,898,000 (-47.46%)

-$35,195,000 (9.31%)

-$38,807,000 (28.89%)

-$54,573,000 (31.87%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$50,265,000 (-52.48%)

-$32,966,000 (14.64%)

-$38,621,000 (25.62%)

-$51,925,000 (26.49%)

Invested Capital

$23,899,000 (123.75%)

$10,681,000 (-31.00%)

$15,480,000 (1278.45%)

$1,123,000 (102.94%)

Working Capital

$9,170,000 (39.32%)

$6,582,000 (71.01%)

$3,849,000 (-95.19%)

$79,951,000 (222.71%)

Tangible Asset Value

$28,178,000 (3.80%)

$27,146,000 (19.78%)

$22,664,000 (-76.52%)

$96,513,000 (103.84%)

Market Capitalization

$55,035,763 (-21.51%)

$70,115,264 (186.88%)

$24,440,281 (-71.87%)

$86,873,801

Average Equity

-$6,770,000 (-130.81%)

$21,970,500 (17.13%)

$18,756,750 (-76.23%)

$78,913,250 (244.75%)

Average Assets

$26,699,000 (-22.34%)

$34,379,750 (-41.74%)

$59,012,750 (-49.88%)

$117,753,000 (297.59%)

Invested Capital Average

$18,857,250 (59.20%)

$11,845,250 (100.83%)

$5,898,250 (255.87%)

-$3,784,000 (84.12%)

Shares

10,791,326 (28.36%)

8,407,106 (179.18%)

3,011,370 (0.52%)

2,995,648 (4.09%)